MedTrace Logo

Prognostic Value of Progesterone for In Vitro Fertilization (IVF) Outcome

NCT01067664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2013-10-18

No results posted yet for this study

Summary

This observational study attempts to investigate the potential role of serum progesterone levels on the day of hCG administration (thus, the end of the follicular phase) on the probability of pregnancy, in patients undergoing IVF with the use of GnRH antagonists and recombinant gonadotrophins.

There has been evidence, that increased serum levels of progesterone are associated with a decreased probability of pregnancy after IVF.

This study will attempt to explore the role of progesterone on the outcome of IVF, by closely monitoring its levels during the late follicular phase.

Conditions

  • Subfertility

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Basil C Tarlatzis, MD, PhD · 1st Dept. of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki

  • Christos A Venetis, MD, MSc · Unit for Human Reproduction, 1st Dept. of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067664 on ClinicalTrials.gov